Verona Pharma American Depositary Share net common equity issued/repurchased for the twelve months ending March 31, 2025 was $0.113B, a 36.08% decline year-over-year.
Verona Pharma American Depositary Share annual net common equity issued/repurchased for 2024 was $0.103B, a 74.83% increase from 2023.
Verona Pharma American Depositary Share annual net common equity issued/repurchased for 2023 was $0.059B, a 61.06% decline from 2022.
Verona Pharma American Depositary Share annual net common equity issued/repurchased for 2022 was $0.151B, a 20523.33% increase from 2021.
Verona Pharma American Depositary Share Net Common Equity Issued/Repurchased 2017-2025 | VRNA